Product Center
Danshen Extract, Tanshinone IIA 5%-50%
Category:
Product Center
Application Areas
Natural Cosmetics
Pharmaceutical Raw Materials
Reference Substance
Product Series
Salvia Extract Series
Product Type
Natural Active Monomer
Keywords:
Service phone:
- Product Description
-
- Commodity name: Danshen Extract, Tanshinone IIA 5%-50%
I. Basic Product Information
Project
Content
Product Name
Danshen extract
English name
Tanshinone IIA
Source
Salvia miltiorrhiza, a plant of the Lamiaceae family Salvia miltiorrhiza Bge. Dried roots and rhizomes
Active ingredient
Tanshinone IIA
CAS No.:
568-72-9
Product Specifications
5%–50%
Detection method
HPLC
Product characteristics
Deep red powder
Solubility
Easily soluble in chloroform , Soluble in organic solvents such as acetone. , Slightly soluble in water
II. Product Introduction
1. Source
Tanshinone IIA It is Salvia miltiorrhiza, a plant of the Lamiaceae family. Salvia miltiorrhiza Bge. A highly purified monomeric ingredient is extracted and refined from dried roots and rhizomes using processes such as ethanol reflux extraction and purification with macroporous resin, thereby maximizing the preservation of the active ingredients’ structure and efficacy. 。
2. Core Efficacy and Applications
( 1 ) Cardiovascular Diseases: Coronary Heart Disease, Angina Pectoris, Myocardial Infarction, Arrhythmia, Hypertension (with Atherosclerosis), Heart Failure.
( 2 ) Cerebrovascular Diseases: Ischemic Stroke (Cerebral Infarction), Cerebral Insufficiency (including vertebral) - Insufficient blood supply to the basilar artery.
( 3 ) Liver Diseases: Chronic Viral Hepatitis, Fatty Liver, Liver Fibrosis.
( 4 ) Adjuvant therapy for tumors: Adjuvant radiotherapy and chemotherapy for various tumors including liver cancer, lung cancer, gastric cancer, breast cancer, and more.
( 5 ) Dermatological conditions: Inflammatory acne (redness and swelling) / Pustular type, eczema, dermatitis.
( 6 ) Other areas: Lower limb arterial atherosclerosis and occlusion, central retinal artery occlusion, benign arrhythmias (accompanied by myocardial ischemia).
III. Technical Specifications and Testing Standards
Testing items
Testing standards
Test results
Detection method
Specifications
≥50.0%
50.2%
HPLC
Characteristics
Deep red powder
Deep red powder
Visual inspection
Smell
Unusual odor
Unusual odor
Sensory evaluation
Granularity
99% passes through an 80-mesh sieve.
99% passes through an 80-mesh sieve.
Sift
Heavy metals
≤10 ppm
<10 ppm
AAS
Lead
≤2 ppm
<2 ppm
AAS
Arsenic
≤2 ppm
<2 ppm
AAS
Moisture
≤5.0%
3.15%
Constant-temperature drying method
Ash content
≤5.0%
1.12%
High-temperature incineration method
Total colony count
≤1000 CFU/g
30 CFU/g
Plate Count Method
Mold yeast
≤100 CFU/g
20 CFU/g
Plate Count Method
Escherichia coli
Not detectable
Not detectable
Selective medium method
Salmonella
Not detectable
Not detectable
Selective enrichment method
IV. Packaging and Storage
1. Packaging specifications
● Small packaging: Sterile aluminum foil pouch (lined with a double-layer polyethylene bag)
● Large packaging: 25 kg cardboard drum (lined with double-layer polyethylene bags, drum lid sealed);
● Export packaging: Packaging available upon request.
2. Storage conditions
● Storage conditions: Store in a sealed, cool, and dry place (temperature ≤25℃, relative humidity ≤60%), and avoid direct sunlight, high temperatures, and humidity.
● Shelf life: 24 months when stored under appropriate conditions and the package remains unopened.
● Transportation precautions: Handle with care and avoid crushing or damage; during transportation, protect from sunlight and moisture.
Previous page
Next page